Phytochemical–SGLT2 Inhibitor Combinations in Type 2 Diabetes: Mechanistic Complementarity, Preclinical Evidence and Translational Perspectives
Type 2 diabetes mellitus (T2DM) is a multifactorial metabolic disorder in which insulin resistance, progressive impairment of pancreatic β-cell function, abnormal hepatic glucose production and disturbances in lipid metabolism contribute to persistent hyperglycemia. Sodium-glucose cotransporter 2 (SGLT2) inhibitors hav...